Edarbi Side Effects

Generic name: azilsartan medoxomil

Medically reviewed by Drugs.com. Last updated on Dec 28, 2023.

Note: This document provides detailed information about Edarbi Side Effects associated with azilsartan medoxomil. Some dosage forms listed on this page may not apply specifically to the brand name Edarbi.

Applies to azilsartan medoxomil: oral tablet.

Common side effects of Edarbi

Some side effects of azilsartan medoxomil may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Serious side effects of Edarbi

Along with its needed effects, azilsartan medoxomil (the active ingredient contained in Edarbi) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking azilsartan medoxomil:

For healthcare professionals

Applies to azilsartan medoxomil: oral tablet.

General adverse events

The most common side effects were diarrhea, dizziness, headache, dyslipidemia, cough, and increased blood creatine phosphokinase.^[Ref]

Gastrointestinal

• Common (1% to 10%): Diarrhea
• Uncommon (0.1% to 1%): Nausea^[Ref]

Nervous system

• Common (1% to 10%): Dizziness, headache
• Frequency not reported: Dizziness postural^[Ref]

Metabolic

• Common (1% to 10%): Dyslipidemia
• Uncommon (0.1% to 1%): Blood uric acid increased, hyperuricemia^[Ref]

Respiratory

• Common (1% to 10%): Cough^[Ref]

Musculoskeletal

• Common (1% to 10%): Blood creatine phosphokinase increased
• Uncommon (0.1% to 1%): Muscle spasm^[Ref]

Dermatologic

• Uncommon (0.1% to 1%): Rash, pruritus
• Rare (less than 0.1%): Angioedema^[Ref]

Other

• Uncommon (0.1% to 1%): Fatigue, peripheral edema
• Frequency not reported: Asthenia^[Ref]

Hematologic

• Uncommon (0.1% to 1%): Low hemoglobin, low hematocrit, low RBC counts^[Ref]

Renal

• Uncommon (0.1% to 1%): Blood creatinine increased^[Ref]

Cardiovascular

• Uncommon (0.1% to 1%): Hypotension^[Ref]

Further information

Edarbi side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.

Medical Disclaimer